The ICH E18 Guideline on Genomic Sampling and Management of Data reaches Step 2b of the ICH Process in December 2015 and now enters the consultation period (Step 3). This new guideline is proposed to provide guidance on genomic sample collection to evaluate efficacy and safety of a drug for regulatory approval.